Stay updated on Tolebrutinib in NRSPMS Clinical Trial

Sign up to get notified when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.
Clouds background image

Latest updates to the Tolebrutinib in NRSPMS Clinical Trial page

  1. Check
    41 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect new timelines and changes in the 9-HPT and T25-FW tests, with the last update date changed to January 2025 and the revision number updated to v2.14.2.
    Difference
    4%
    Check dated 2025-02-06T21:49:11.000Z thumbnail image
  2. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-22T11:30:17.000Z thumbnail image
  3. Check
    71 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.1%
    Check dated 2025-01-08T03:13:24.000Z thumbnail image
  4. Check
    92 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.0%
    Check dated 2024-12-17T12:53:47.000Z thumbnail image
  5. Check
    100 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    1%
    Check dated 2024-12-09T22:34:37.000Z thumbnail image
  6. Check
    114 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.1 to v2.12.2.
    Difference
    0.0%
    Check dated 2024-11-25T13:50:26.000Z thumbnail image

Stay in the know with updates to Tolebrutinib in NRSPMS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.